by 21st Century Competition | Jun 19, 2014 | Global Blogs
The Common Core standardized testing initiative has earned its fair share of controversy in recent months as some criticized the grade school standards as ineffective and unnecessarily complicated, but now the Common Core is surrounded by more controversy; this time,...
by 21st Century Competition | Jun 19, 2014 | Global Blogs
The European Commission could issue fines to the world’s largest generic drug makers as early as next month, according to unnamed sources. Leading generic firms Teva Pharmaceutical and Les Laboratoires Servier, along with other generic competitors, are under the...
by 21st Century Competition | Jun 19, 2014 | Global Blogs
In a highly anticipated decision, the Supreme Court on June 12 announced that compliance with food labeling guidelines promulgated by the Food and Drug Administration will not operate as a bar against false advertising claims brought under the Lanham Act. In its...
by 21st Century Competition | Jun 19, 2014 | Global Blogs
Z Technologies Corp. v. Lubrizol Corp., No. 2:12-cv-12206 (6th Cir., May 23, 2014). In February, 2007, Lubrizol Corporation made a “merger to monopoly” acquisition of the assets of a competitor. The acquisition established a monopoly in the market for petroleum...
by 21st Century Competition | Jun 19, 2014 | Global Blogs
Hogan Lovells Last week, the Polish Lower Chamber of Parliament agreed final changes to Poland’s competition law regime. The new regime, which will be implemented by amendments to the Polish Act on Competition and Consumer Protection, is likely to come into...
